Cymbalta
| Generic Name: | duloxetine |
| Company: | Eli Lilly and Company |
| Web Site: | www.cymbalta.com/index.jsp |
| Country: | USA |
| |
 |
Description: |
Cymbalta (duloxetine hydrochloride) is a selective serotonin and norepinephrine reuptake inhibitor (SSNRI) for oral administration. |
| |
| Indications: | Cymbalta is approved by the FDA for the acute and maintenance treatment of major depressive disorder (MDD).
Cymbalta is approved by the FDA for the acute treatment of generalized anxiety disorder (GAD).
Revised April 2009 |
| |
| |
| |
|
|
|
|
Additional Information
Medications for
Mental Illness
Your Child
and Medications
Bipolar
Disorder
Schizophrenia
Guide
Depression
|
